Provided by Tiger Trade Technology Pte. Ltd.

Aesthetic Medicine

938.176
-13.667-1.44%
Number of Gainers:5
Number of Losers:5
Number of Flat:3
PE:- -
High:961.507
Open:951.300
Low:931.555
Close:951.843
Volume:153.85M
Turnover:893.88M
Market Cap:153.94B
Float Cap:116.09B

Loading ...

Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand

Reuters
·
Yesterday

China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%

Reuters
·
Yesterday

Sihuan Pharma FY26 H1 Profit Attributable to Owners Rises 119% to RMB 224.7 Million; Revenue Increases 1.3% to RMB 1.16 Billion

Reuters
·
Yesterday

Sihuan Pharmaceutical Files Board, Committee Roles and Disclosure-Responsible Management List

Reuters
·
Yesterday

Sinopharm Group Stock Rallies 1.1% in Hong Kong

Dow Jones
·
Yesterday

Global Equities Roundup: Market Talk

Dow Jones
·
Yesterday

Fosun Pharma's H1 Report: Innovative Drug Revenue Surges 13.8% as Global Expansion Spans Three Continents

Deep News
·
Yesterday

SIHUAN PHARM Posts 119% Profit Surge in Interim Results, Reinforcing Dual-Engine Strategy

Stock News
·
Yesterday

Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength

Reuters
·
Yesterday

Sihuan Pharmaceutical Holdings Group H1 Net Income Attributable RMB 224.7 Million

THOMSON REUTERS
·
Yesterday

Sihuan Pharma Appoints Song Xiaomi as CFO

Reuters
·
Yesterday

Sihuan Pharma - Appoints Song Xiaomi as Chief Financial Officer Effective 26 August 2026

THOMSON REUTERS
·
Yesterday

Sihuan Pharma - Miao Guili Resigns as Executive Director, Deputy CEO, and CFO Effective 26 August 2026

THOMSON REUTERS
·
Yesterday

Fosun Pharma Posts Flat Profit Growth in H1, Revenue Up 4.8%

MT Newswires Live
·
Yesterday

Press Release: Fosun Pharma Announces 2026 Interim Results

Dow Jones
·
Aug 25

Haohai Biotec Allocates HK$3.94 Million to Buy Back Nearly 250,000 Shares

Stock News
·
Aug 24

Sinopharm Group Stock Falls 1.9% in Hong Kong

Dow Jones
·
Aug 24

CICC Keeps Outperform Rating on 3SBIO, Trims Target Price to HK$30.00

Stock News
·
Aug 24

Shanghai Haohai Biological Technology (SEHK:6826) Stock Hit By Margin Compression And Profit Drop

Simply Wall St.
·
Aug 23

HAOHAI BIOTEC Sets October Dividend Date for Interim Payout

Stock News
·
Aug 21